Table 2.
Number of patients for each DEmiRNA identified in urine EVs and serum supernatants. Tables A and B show the number out of the fourteen T1 patients where the expression was higher in the presurgery vs. postsurgery for the 11 DEmiRNA from urine EVs (Figure 2D) and for the 12 DEmiRNA from serum supernatant (Figure 2F).
| (A) Urine EVs | (B) Serum Supernatant | ||
|---|---|---|---|
| miR-486-5p | 12 | miR-3158-3p | 9 |
| miR-451a | 12 | miR-3921-3p | 7 |
| miR-205-5p | 11 | miR-4654-3p | 9 |
| miR-1246 | 10 | miR-922-3p | 11 |
| miR-483-3p | 12 | miR-612-3p | 7 |
| miR-1323 | 14 | miR-4453-3p | 8 |
| miR-6073-3p | 11 | miR-942-3p | 7 |
| miR-202-3p | 8 | miR-4734-3p | 9 |
| miR-4508-5p | 8 | miR-185-3p | 8 |
| miR-483-5p | 9 | miR-6851-5p | 9 |
| miR-6768-5p | 8 | miR-135a-1-3p | 3 |
| miR-3153-3p | 3 |